BR0010060A - Esteróides 3<244>-hidroxi-3<225>-metoximetil-21-heterocìclo substituìdos com atividade anestésica - Google Patents

Esteróides 3<244>-hidroxi-3<225>-metoximetil-21-heterocìclo substituìdos com atividade anestésica

Info

Publication number
BR0010060A
BR0010060A BR0010060-9A BR0010060A BR0010060A BR 0010060 A BR0010060 A BR 0010060A BR 0010060 A BR0010060 A BR 0010060A BR 0010060 A BR0010060 A BR 0010060A
Authority
BR
Brazil
Prior art keywords
hydroxy
steroids
methoxymethyl
anesthetic activity
heterocycle replaced
Prior art date
Application number
BR0010060-9A
Other languages
English (en)
Inventor
Derk J Hogenkamp
Original Assignee
Purdue Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Pharma Ltd filed Critical Purdue Pharma Ltd
Publication of BR0010060A publication Critical patent/BR0010060A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

"ESTERóIDES 3<244>-HIDROXI-3<225>-METOXIMETIL-21-HETEROCìCLO SUBSTITUìDOS COM ATIVIDADE ANESTéSICA". Essa invenção se refere a compostos possuindo a Fórmula (I) ou um sal farmaceuticamente aceitável, pró-droga ou solvato deles provenientes, onde R~ 1~ é H ou metila; R~ 2~ é 5<244>- ou 5<225>-H; R~ 3~ é um grupo heteroarila N-anexado opcionalmente substituído ou um grupo -X-R~ 4~; R~ 4~ é um grupo heteroarila carbono-anexado opcionalmente substituído; e X é O, S, ou N. A invenção também está direcionada ao uso de esteróides 3<244>-hidroxi-3<225>-metoximetil-substituídos como sedativos/hipnóticos e para induzir anestesia.
BR0010060-9A 1999-04-29 2000-04-28 Esteróides 3<244>-hidroxi-3<225>-metoximetil-21-heterocìclo substituìdos com atividade anestésica BR0010060A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13157899P 1999-04-29 1999-04-29
PCT/US2000/011680 WO2000066614A1 (en) 1999-04-29 2000-04-28 3α-HYDROXY-3β METHOXYMETHYL-21-HETEROCYCLE SUBSTITUTED STEROIDS WITH ANESTHETIC ACTIVITY

Publications (1)

Publication Number Publication Date
BR0010060A true BR0010060A (pt) 2002-01-15

Family

ID=22450073

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010060-9A BR0010060A (pt) 1999-04-29 2000-04-28 Esteróides 3<244>-hidroxi-3<225>-metoximetil-21-heterocìclo substituìdos com atividade anestésica

Country Status (20)

Country Link
US (2) US20040034002A1 (pt)
EP (1) EP1177206A1 (pt)
JP (1) JP2002543218A (pt)
KR (1) KR20020013530A (pt)
CN (1) CN1187367C (pt)
AU (1) AU780989B2 (pt)
BR (1) BR0010060A (pt)
CA (1) CA2372342A1 (pt)
CZ (1) CZ20013867A3 (pt)
HU (1) HUP0201818A3 (pt)
IL (1) IL146230A0 (pt)
MX (1) MXPA01010915A (pt)
NO (1) NO321536B1 (pt)
NZ (1) NZ515779A (pt)
PL (1) PL351438A1 (pt)
RU (1) RU2243232C2 (pt)
UA (1) UA73736C2 (pt)
WO (1) WO2000066614A1 (pt)
YU (1) YU77701A (pt)
ZA (1) ZA200109847B (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090118248A1 (en) * 2004-04-23 2009-05-07 Euro-Celtique S.A. 3-Alpha-hydroxy 21-n-heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof
US20060074059A1 (en) * 2004-08-26 2006-04-06 Goliber Philip A Isomorphic crystalline habits of 3alpha-hydroxy-21-(1'-imidazolyl)-3beta-methoxymethyl-5alpha-pregnane-20-one
PT2168585E (pt) * 2005-06-09 2012-03-05 Euro Celtique Sa Composições farmacêuticas de um esteróide neuroactivo e as suas utilizações
DE102008058436B4 (de) 2008-11-21 2019-03-07 Osram Opto Semiconductors Gmbh Kantenemittierender Halbleiterlaserchip
US20150158903A1 (en) 2011-09-08 2015-06-11 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
ES2738526T3 (es) * 2011-10-14 2020-01-23 Sage Therapeutics Inc Compuestos 19-norpregnano 3,3-disustituidos, composiciones y usos de los mismos
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
HRP20200995T1 (hr) 2013-04-17 2020-11-27 Sage Therapeutics, Inc. 19-nor neuroaktivni steroidi za metode liječenja
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
HRP20190232T1 (hr) 2013-04-17 2019-03-22 Sage Therapeutics, Inc. 19-nor c3,3-disupstituirani c21-n-pirazolil steroidi i postupci za njihovu upotrebu
SMT202100229T1 (it) 2013-07-19 2021-05-07 Sage Therapeutics Inc Steroidi neuroattivi, composizioni e loro usi
SMT202100048T1 (it) 2013-08-23 2021-03-15 Sage Therapeutics Inc Steroidi neuroattivi, composizioni e loro usi
HUE050028T2 (hu) * 2014-05-29 2021-12-28 Sage Therapeutics Inc Neuroaktív szteroidok, készítmények és alkalmazásuk
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
AU2015331749A1 (en) 2014-10-16 2017-05-04 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
JP6742308B2 (ja) 2014-10-16 2020-08-19 セージ セラピューティクス， インコーポレイテッド Ｃｎｓ障害を処置するための組成物および方法
ES2793237T3 (es) 2014-11-27 2020-11-13 Sage Therapeutics Inc Composiciones y métodos para el tratamiento de trastornos del SNC
SI3250210T1 (sl) 2015-01-26 2021-07-30 Sage Therapeutics, Inc. Sestavki in metode za zdravljenje CNS motenj
US10329320B2 (en) 2015-02-20 2019-06-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
MX376833B (es) 2015-07-06 2025-03-07 Sage Therapeutics Inc Oxiesteroles y metodos de uso de los mismos.
CN114272249A (zh) 2016-04-01 2022-04-05 萨奇治疗股份有限公司 氧甾醇及其使用方法
AU2017296295B2 (en) 2016-07-11 2022-02-24 Sage Therapeutics, Inc. C7, C12, and C16 substituted neuroactive steroids and their methods of use
CN109689673B (zh) * 2016-07-11 2023-03-14 萨奇治疗股份有限公司 C17、c20和c21取代的神经活性类固醇及其使用方法
EP3519422B1 (en) 2016-09-30 2022-08-31 Sage Therapeutics, Inc. C7 substituted oxysterols and these compounds for use as nmda modulators
KR20250054838A (ko) 2016-10-18 2025-04-23 세이지 테라퓨틱스, 인크. 옥시스테롤 및 그의 사용 방법
US10562930B1 (en) * 2018-08-31 2020-02-18 Praxis Precision Medicines, Inc. Salts and crystal forms of GABAA positive allosteric modulator
AU2019406803B2 (en) * 2018-12-17 2025-04-24 Intra-Cellular Therapies, Inc. Organic compounds
CN114206900A (zh) 2019-05-31 2022-03-18 萨奇治疗股份有限公司 神经活性类固醇及其组合物
US20230346801A1 (en) 2020-03-25 2023-11-02 Sage Therapeutics, Inc. Use of agents for treatment of respiratory conditions
WO2022040545A1 (en) * 2020-08-20 2022-02-24 Intra-Cellular Therapies, Inc. Organic compounds
US20240148756A1 (en) 2021-02-18 2024-05-09 Sage Therapeutics, Inc. Use of neuroactive steroid for treatment of sexual dysfunction
WO2023159035A1 (en) 2022-02-16 2023-08-24 Sage Therapeutics, Inc. Neuroactive steroids for treatment of cns-related disorders
WO2023159094A2 (en) * 2022-02-16 2023-08-24 Praxis Precision Medicines, Inc. PROCESS OF MAKING 3α-HYDROXY-3β-METHOXYMETHYL-21-(1'- IMIDAZOLYL)-5α-PREGNAN-20-ONE
US20250170148A1 (en) 2022-02-28 2025-05-29 Sage Therapeutics, Inc. Neuroactive steroids for treatment of gastrointestinal diseases or conditions
EP4711377A1 (en) * 2023-05-11 2026-03-18 Shujing Biopharma Co., Ltd Steroid compound, preparation method therefor, and use thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1377608A (en) * 1970-12-17 1974-12-18 Glaxo Lab Ltd 3alpha-hydroxy or acyloxy pregnene-21-ethers
US3953429A (en) * 1970-12-17 1976-04-27 Glaxo Laboratories Limited Anaesthetic steroids of the androstance and pregnane series
US3969345A (en) * 1970-12-17 1976-07-13 Glaxo Laboratories Limited 20β,21-Epoxy-3α-hydroxy-5α-pregnanes and derivatives thereof
US3943124A (en) * 1970-12-17 1976-03-09 Gordon Hanley Phillipps Chemical compounds
US3959260A (en) * 1972-05-05 1976-05-25 Glaxo Laboratories Limited Anaesthetic steroids of the pregnane and 19-norpregnane series having a sulfur-containing group at the 21-position
GB1436324A (en) * 1972-05-12 1976-05-19 Glaxo Lab Ltd Anaesthetic 3alpha-hydroxy pregnanes
US4192871A (en) * 1976-01-06 1980-03-11 Glaxo Laboratories Limited Chemical compounds
US4197296A (en) * 1977-03-23 1980-04-08 Glaxo Group Limited Androstanes
US4297350A (en) * 1978-10-10 1981-10-27 The Upjohn Company Male contraceptive steroids and methods of use
US5208227A (en) * 1987-08-25 1993-05-04 University Of Southern California Method, compositions, and compounds for modulating brain excitability
US5120723A (en) * 1987-08-25 1992-06-09 University Of Southern California Method, compositions, and compounds for modulating brain excitability
US5319115A (en) * 1987-08-25 1994-06-07 Cocensys Inc. Method for making 3α-hydroxy, 3β-substituted-pregnanes
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
NZ282939A (en) * 1994-02-14 1998-08-26 Cocensys Inc Androstanes and pregnanes for allosteric modulation of gaba receptors
US5939545A (en) * 1994-02-14 1999-08-17 Cocensys, Inc. Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
KR19990022323A (ko) * 1995-06-06 1999-03-25 씨. 랜 낸시 안드로스탄 및 프레그난 시리즈의 신경활성 스테로이드

Also Published As

Publication number Publication date
HUP0201818A3 (en) 2004-04-28
CN1360591A (zh) 2002-07-24
CA2372342A1 (en) 2000-11-09
NZ515779A (en) 2003-11-28
NO20015262L (no) 2001-12-19
ZA200109847B (en) 2003-02-26
NO20015262D0 (no) 2001-10-26
US20040034002A1 (en) 2004-02-19
EP1177206A1 (en) 2002-02-06
YU77701A (sh) 2005-07-19
RU2243232C2 (ru) 2004-12-27
IL146230A0 (en) 2002-07-25
WO2000066614A1 (en) 2000-11-09
US20050171074A1 (en) 2005-08-04
MXPA01010915A (es) 2002-11-07
HK1047594A1 (en) 2003-02-28
AU780989B2 (en) 2005-04-28
KR20020013530A (ko) 2002-02-20
JP2002543218A (ja) 2002-12-17
WO2000066614A8 (en) 2001-03-15
CZ20013867A3 (cs) 2002-07-17
PL351438A1 (en) 2003-04-22
AU4810400A (en) 2000-11-17
UA73736C2 (en) 2005-09-15
CN1187367C (zh) 2005-02-02
HUP0201818A2 (en) 2002-10-28
NO321536B1 (no) 2006-05-22

Similar Documents

Publication Publication Date Title
BR0010060A (pt) Esteróides 3&lt;244&gt;-hidroxi-3&lt;225&gt;-metoximetil-21-heterocìclo substituìdos com atividade anestésica
BRPI0111015B8 (pt) composto antagonista de receptor a2a de adenosina, composição farmacêutica compreendendo o mesmo, seu uso e processos para a preparação de compostos intermediários
BR0015843A (pt) Antagonista de y5 para npy
AU2003301020A8 (en) Isoquinolinone derivatives and their use as therapeutic agents
BR0115446A (pt) Processos para tratamento de condições associadas a quinase p38 e compostos pirrolotriazina úteis como inibidores de quinase
BR0102083A (pt) Uso de derivados de alfa-cetoenamina como ingredientes
JO2503B1 (en) Benzathiazole derivatives
PA8484201A1 (es) Derivados de adenina
CY1110914T1 (el) Δικυκλο-πυραζολες δραστικες ως αναστολεις kinασων, διεργασια για την παρασκευη τους και φαρμακευτικες συνθεσεις που τις περιλαμβανουν
BRPI0111639B8 (pt) uso de uma molécula de ácido oligodeoxinucléico imunoestimulatório e composição farmacêutica.
ECSP066311A (es) Derivados de la piperazina y su uso como agentes terapéuticos
ES2295609T3 (es) Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor.
ATE284861T1 (de) N-aralkylaminotetraline als neuropeptid-y-y5- rezeptorliganden
MXPA03001344A (es) Derivados de piridina 2,4-substituidos.
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
DOP2000000114A (es) Oxazolidinonas substituidas y su uso
BR9914638A (pt) Composto, método para a preparação do mesmo, composição farmacêutica, uso de um composto, e, método para o tratamento de um distúrbio ou doença de um corpo de animal vivo
BG107171A (bg) Производни на пурин
BRPI0413232B8 (pt) composto tendo atividade inibitória contra transportador dependente de sódio, composição farmacêutica compreendendo o composto, uso do composto na preparação de um medicamento e processo para a preparação do composto
HUP0202490A2 (hu) Indazolszármazékok és ezeket tartalmazó protein-kináz gátló hatású gyógyszerkészítmények
BRPI0606817A2 (pt) derivados de piridazina e seu uso como agentes terapêuticos
SE9904508D0 (sv) New compounds
BR0014136A (pt) Composto, uso do mesmo, métodos para a preparação de um composto, e para inibir aurora 2 quinase em um animal de sangue quente, e, composição farmacêutica
BR0011850A (pt) Agonistas de receptor a2a de propargil fenil éter
BR0007229A (pt) Aminoazaciclos heterocìclicos substituìdos úteis como agentes de sistema nervoso central

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: EURO-CELTIQUE S.A (LU)

Free format text: TRANSFERIDO DE: PURDUE PHARMA LTD.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 8A. E 9A. ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI2003 DE 26/05/2009.